Clinical Trial Update: Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update outlining dose-finding in a sequential Phase I–II study of propranolol with metronomic fixed oral cyclophosphamide for locally advanced or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Propranolol (propranolol)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Angiosarcoma | Phase 1, Phase 2 | Status: UNKNOWN